Aakash Chovatia
@ChovatiaAakash
May 1st, 2020 23:52
Equity Advisor at Motilal Oswal Financial Services
Aakash Chovatia
@ChovatiaAakash
May 1st, 2020 23:52
Equity Advisor at Motilal Oswal Financial Services
Feeds
9Following
0Followers
0Likes
0Top scripts
Overall User Sentiment
Our Sponsors
Our Sponsors
ChovatiaAakash
@ChovatiaAakash
July 3rd, 2023 07:35
RT @SumitResearch: Block Deals Adani Trans 3.39 Cr Share Sold By Fortitude Trade (Promoter) 1.40 Cr Share buy Goldman Sachs 72.5 Lk Share…
RT @SumitResearch: Block Deals Adani Trans 3.39 Cr Share Sold By Fortitude Trade (Promoter) 1.40 Cr Share buy Goldman Sachs 72.5 Lk Share…
ChovatiaAakash
@ChovatiaAakash
July 3rd, 2023 07:35
RT @SumitResearch: Block Deals Adani Trans 3.39 Cr Share Sold By Fortitude Trade (Promoter) 1.40 Cr Share buy Goldman Sachs 72.5 Lk Share…
July 3rd, 2023 07:35
RT @SumitResearch: Block Deals Adani Trans 3.39 Cr Share Sold By Fortitude Trade (Promoter) 1.40 Cr Share buy Goldman Sachs 72.5 Lk Share…
ChovatiaAakash
@ChovatiaAakash
June 22nd, 2023 08:26
RT @NeerajCNBC: MOFSL on Tube Investment Buy Rating Target Rs 3,560 Recovery In Engineering Business Expected In FY24 EV Businesses Moving…
RT @NeerajCNBC: MOFSL on Tube Investment Buy Rating Target Rs 3,560 Recovery In Engineering Business Expected In FY24 EV Businesses Moving…
ChovatiaAakash
@ChovatiaAakash
June 22nd, 2023 08:26
RT @NeerajCNBC: MOFSL on Tube Investment Buy Rating Target Rs 3,560 Recovery In Engineering Business Expected In FY24 EV Businesses Moving…
June 22nd, 2023 08:26
RT @NeerajCNBC: MOFSL on Tube Investment Buy Rating Target Rs 3,560 Recovery In Engineering Business Expected In FY24 EV Businesses Moving…
ChovatiaAakash
@ChovatiaAakash
June 2nd, 2023 08:10
RT @NeerajCNBC: Jefferies on Bajaj Finance Maintain Buy Rating Target Raised To Rs 8,310 From 7,280 See Co Delivering A Healthy 27% CAGR In…
RT @NeerajCNBC: Jefferies on Bajaj Finance Maintain Buy Rating Target Raised To Rs 8,310 From 7,280 See Co Delivering A Healthy 27% CAGR In…
ChovatiaAakash
@ChovatiaAakash
June 2nd, 2023 08:10
RT @NeerajCNBC: Jefferies on Bajaj Finance Maintain Buy Rating Target Raised To Rs 8,310 From 7,280 See Co Delivering A Healthy 27% CAGR In…
June 2nd, 2023 08:10
RT @NeerajCNBC: Jefferies on Bajaj Finance Maintain Buy Rating Target Raised To Rs 8,310 From 7,280 See Co Delivering A Healthy 27% CAGR In…
ChovatiaAakash
@ChovatiaAakash
May 26th, 2023 08:03
RT @NeerajCNBC: Investec on Radico Khaitan Hold Rating Target Rs 1,082 Cost Pressures Depress Margin, All Eyes On Capex Execution Rev Growt…
RT @NeerajCNBC: Investec on Radico Khaitan Hold Rating Target Rs 1,082 Cost Pressures Depress Margin, All Eyes On Capex Execution Rev Growt…
ChovatiaAakash
@ChovatiaAakash
May 26th, 2023 08:03
RT @NeerajCNBC: Investec on Radico Khaitan Hold Rating Target Rs 1,082 Cost Pressures Depress Margin, All Eyes On Capex Execution Rev Growt…
May 26th, 2023 08:03
RT @NeerajCNBC: Investec on Radico Khaitan Hold Rating Target Rs 1,082 Cost Pressures Depress Margin, All Eyes On Capex Execution Rev Growt…
ChovatiaAakash
@ChovatiaAakash
May 12th, 2023 13:37
RT @YatinMota: Balrampur Chini slips to Rs 400 levels Buy Back also ends on Monday i.e. 15th May 2023
RT @YatinMota: Balrampur Chini slips to Rs 400 levels Buy Back also ends on Monday i.e. 15th May 2023
ChovatiaAakash
@ChovatiaAakash
May 12th, 2023 13:37
RT @YatinMota: Balrampur Chini slips to Rs 400 levels Buy Back also ends on Monday i.e. 15th May 2023
May 12th, 2023 13:37
RT @YatinMota: Balrampur Chini slips to Rs 400 levels Buy Back also ends on Monday i.e. 15th May 2023
ChovatiaAakash
@ChovatiaAakash
February 14th, 2023 06:16
RT @ETMarkets: #StockRadar: Buy Mphasis for a target of Rs 2240, Shivangi Sarda (@shivangisarda), Analyst, Derivatives and Technical Resear…
RT @ETMarkets: #StockRadar: Buy Mphasis for a target of Rs 2240, Shivangi Sarda (@shivangisarda), Analyst, Derivatives and Technical Resear…
ChovatiaAakash
@ChovatiaAakash
February 14th, 2023 06:16
RT @ETMarkets: #StockRadar: Buy Mphasis for a target of Rs 2240, Shivangi Sarda (@shivangisarda), Analyst, Derivatives and Technical Resear…
February 14th, 2023 06:16
RT @ETMarkets: #StockRadar: Buy Mphasis for a target of Rs 2240, Shivangi Sarda (@shivangisarda), Analyst, Derivatives and Technical Resear…
ChovatiaAakash
@ChovatiaAakash
September 30th, 2022 08:57
RT @SumitResearch: *Insider Trades* *Maharashtra Seamless:* Promoter buy 50k shon Sept. 28. *Elecon Engineering Company:* Promoter buy…
RT @SumitResearch: *Insider Trades* *Maharashtra Seamless:* Promoter buy 50k shon Sept. 28. *Elecon Engineering Company:* Promoter buy…
ChovatiaAakash
@ChovatiaAakash
September 30th, 2022 08:57
RT @SumitResearch: *Insider Trades* *Maharashtra Seamless:* Promoter buy 50k shon Sept. 28. *Elecon Engineering Company:* Promoter buy…
September 30th, 2022 08:57
RT @SumitResearch: *Insider Trades* *Maharashtra Seamless:* Promoter buy 50k shon Sept. 28. *Elecon Engineering Company:* Promoter buy…
ChovatiaAakash
@ChovatiaAakash
September 4th, 2022 11:38
RT @PRSundar64: Best stock to buy now? Mind Voice: Suzlon.
RT @PRSundar64: Best stock to buy now? Mind Voice: Suzlon.
ChovatiaAakash
@ChovatiaAakash
September 4th, 2022 11:38
RT @PRSundar64: Best stock to buy now? Mind Voice: Suzlon.
September 4th, 2022 11:38
RT @PRSundar64: Best stock to buy now? Mind Voice: Suzlon.
ChovatiaAakash
@ChovatiaAakash
December 20th, 2021 08:13
RT @SumitResearch: Nomura On Cipla Buy Call, Target At `1,051/Sh Got US FDA Approval For Lanreotide Depot Injection Under 505b(2) Pathway…
RT @SumitResearch: Nomura On Cipla Buy Call, Target At `1,051/Sh Got US FDA Approval For Lanreotide Depot Injection Under 505b(2) Pathway…
ChovatiaAakash
@ChovatiaAakash
December 20th, 2021 08:13
RT @SumitResearch: Nomura On Cipla Buy Call, Target At `1,051/Sh Got US FDA Approval For Lanreotide Depot Injection Under 505b(2) Pathway…
December 20th, 2021 08:13
RT @SumitResearch: Nomura On Cipla Buy Call, Target At `1,051/Sh Got US FDA Approval For Lanreotide Depot Injection Under 505b(2) Pathway…